Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 10 | 14 | 24 |
| 1996 | 12 | 18 | 30 |
| 1997 | 17 | 26 | 43 |
| 1998 | 16 | 22 | 38 |
| 1999 | 14 | 28 | 42 |
| 2000 | 27 | 45 | 72 |
| 2001 | 20 | 36 | 56 |
| 2002 | 34 | 33 | 67 |
| 2003 | 56 | 42 | 98 |
| 2004 | 44 | 48 | 92 |
| 2005 | 68 | 45 | 113 |
| 2006 | 60 | 42 | 102 |
| 2007 | 58 | 65 | 123 |
| 2008 | 74 | 45 | 119 |
| 2009 | 69 | 61 | 130 |
| 2010 | 76 | 63 | 139 |
| 2011 | 94 | 70 | 164 |
| 2012 | 101 | 68 | 169 |
| 2013 | 120 | 104 | 224 |
| 2014 | 148 | 100 | 248 |
| 2015 | 136 | 96 | 232 |
| 2016 | 128 | 97 | 225 |
| 2017 | 157 | 92 | 249 |
| 2018 | 157 | 119 | 276 |
| 2019 | 164 | 98 | 262 |
| 2020 | 144 | 164 | 308 |
| 2021 | 79 | 189 | 268 |
| 2022 | 22 | 208 | 230 |
| 2023 | 12 | 222 | 234 |
| 2024 | 72 | 99 | 171 |
| 2025 | 5 | 6 | 11 |
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer. Sci Rep. 2025 Feb 28; 15(1):7220.
-
Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma. Nat Commun. 2025 Feb 20; 16(1):1824.
-
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma. Cancer. 2025 Feb 15; 131(4):e35751.
-
A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence. Neuro Oncol. 2025 Feb 10; 27(2):445-454.
-
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy. J Viral Hepat. 2025 Feb; 32(2):e14056.
-
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]). Breast Cancer Res. 2025 Jan 23; 27(1):12.
-
Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence. J Clin Endocrinol Metab. 2025 Jan 21; 110(2):e294-e300.
-
Treatment advances across the cervical cancer spectrum. Nat Rev Clin Oncol. 2025 Mar; 22(3):182-199.
-
PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging. JAMA Netw Open. 2025 Jan 02; 8(1):e2452971.
-
Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer. Cancer Res Commun. 2025 Jan 01; 5(1):119-127.